Fecal microbiota transplantation in Parkinson's disease-A randomized repeat-dose, placebo-controlled clinical pilot study.
Saved in:
| Title: | Fecal microbiota transplantation in Parkinson's disease-A randomized repeat-dose, placebo-controlled clinical pilot study. |
|---|---|
| Authors: | DuPont HL; Microbiome Research Center, Kelsey Research Foundation, Houston, TX, United States.; Division of Epidemiology, Human Genetics and Environmental Sciences, University of Texas School of Public Health, Houston, TX, United States.; Department of Internal Medicine, University of Texas McGovern Medical School, Houston, TX, United States.; Medical Services and Specialties, Kelsey Seybold Clinic, Houston, TX, United States., Suescun J; Department of Neurology, University of Texas McGovern Medical School, Houston, TX, United States., Jiang ZD; Division of Epidemiology, Human Genetics and Environmental Sciences, University of Texas School of Public Health, Houston, TX, United States., Brown EL; Division of Epidemiology, Human Genetics and Environmental Sciences, University of Texas School of Public Health, Houston, TX, United States., Essigmann HT; Division of Epidemiology, Human Genetics and Environmental Sciences, University of Texas School of Public Health, Houston, TX, United States., Alexander AS; Microbiome Research Center, Kelsey Research Foundation, Houston, TX, United States., DuPont AW; Department of Internal Medicine, University of Texas McGovern Medical School, Houston, TX, United States., Iqbal T; Division of Epidemiology, Human Genetics and Environmental Sciences, University of Texas School of Public Health, Houston, TX, United States., Utay NS; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, United States., Newmark M; Microbiome Research Center, Kelsey Research Foundation, Houston, TX, United States.; Medical Services and Specialties, Kelsey Seybold Clinic, Houston, TX, United States., Schiess MC; Department of Neurology, University of Texas McGovern Medical School, Houston, TX, United States. |
| Source: | Frontiers in neurology [Front Neurol] 2023 Mar 02; Vol. 14, pp. 1104759. Date of Electronic Publication: 2023 Mar 02 (Print Publication: 2023). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101546899 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2295 (Print) Linking ISSN: 16642295 NLM ISO Abbreviation: Front Neurol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!